Medidata Solutions Stock Price, News & Analysis (NASDAQ:MDSO)

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

Medidata Solutions Inc (NASDAQ:MDSO) released its quarterly earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.17 by $0.31. The firm earned $180.50 million during the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The company's revenue for the quarter was up 15.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.43 earnings per share. View Medidata Solutions' Earnings History.

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, October 17th 2019. View Earnings Estimates for Medidata Solutions.

9 equities research analysts have issued 1-year price targets for Medidata Solutions' shares. Their predictions range from $70.00 to $96.00. On average, they expect Medidata Solutions' share price to reach $84.43 in the next year. This suggests that the stock has a possible downside of 8.2%. View Analyst Price Targets for Medidata Solutions.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

News stories about MDSO stock have trended very negative on Thursday, InfoTrie reports. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medidata Solutions earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Medidata Solutions.

Some companies that are related to Medidata Solutions include Veeva Systems (VEEV), Synopsys (SNPS), ANSYS (ANSS), Cadence Design Systems (CDNS), Splunk (SPLK), Check Point Software Technologies (CHKP), Twilio (TWLO), Atlassian (TEAM), Tableau Software (DATA), Symantec (SYMC), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Okta (OKTA), Citrix Systems (CTXS), SS&C Technologies (SSNC) and Paycom Software (PAYC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), Gilead Sciences (GILD), Allergan (AGN), salesforce.com (CRM), IBM (IBM), Alphabet (GOOG), Intel (INTC), Ionis Pharmaceuticals (IONS) and Western Digital (WDC).

Medidata Solutions' stock is owned by many different of institutional and retail investors. Top institutional investors include Assenagon Asset Management S.A. (0.88%), Havens Advisors LLC (0.08%), Pacer Advisors Inc. (0.04%), State of Alaska Department of Revenue (0.02%) and Cerebellum GP LLC (0.01%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.

MDSO stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc.. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael I Otner, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.

MDSO stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Havens Advisors LLC, State of Alaska Department of Revenue and Cerebellum GP LLC. View Insider Buying and Selling for Medidata Solutions.

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDSO stock can currently be purchased for approximately $91.94.

Medidata Solutions has a market capitalization of $5.74 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions.

The official website for Medidata Solutions is http://www.mdsol.com/.

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]